Bellus Health

$2.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.99%) As of 9:28 AM EST pre-market

Why Robinhood?

You can buy or sell Bellus Health and other stocks, options, and ETFs commission-free!

About BLU

BELLUS Health Inc. Common Shares, also called Bellus Health, is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. The listed name for BLU is BELLUS Health Inc. Common Shares.

CEO
Roberto Bellini
Employees
Headquarters
Laval, Québec
Founded
1993
Market Cap
236.58M
Price-Earnings Ratio
Dividend Yield
Average Volume
4.20M
High Today
$3.24
Low Today
$3.00
Open Price
$3.16
Volume
2.62M
52 Week High
$12.03
52 Week Low
$2.01

Collections

BLU Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.09 per share

You May Also Like